The probiotic potential of 3 yeasts strains of Saccharomyces cerevisiae isolated from kefirs and feces was investigated and compared with 3 isolates from medicines and 2 collection strains (ATCC) of Saccharomyces cerevisiae var. boulardii. Genetic identification of yeasts based on karyotypes indicated their affiliation to Saccharomyces spp. although chromosomal polymorphism was observed. Concerning probiotic characteristics survival in simulated gastric and intestinal environment were examined. The survival of all tested yeasts in medium of pH 2.5 was comparable and equaled 86.897.1% after 8 hours of incubation at 37°C. The fecal isolate, probiotic and collection yeasts showed also high resistance to pH 1.5 and their survival was 85.392.1%, whereas for kefir strains it amounted to 33.1 and 38.9%. All yeasts tested demonstrated high resistance to synthetic bile salts as well. In the presence of 0.1% sodium cholate and sodium deoxycholate the reduction of cell number by only 1 log unit after 4 hours of incubation at 37°C was observed. However, 1.0% addition of ox bile did not affect their viability. In simulated gastric and intestinal environment survival of fecal, probiotic and collection strains was 86.393.7% after 4 hours of incubation in media with addition of 3 g/l pepsin and 1 g/l pancreatin. Kefir isolates were more sensitive to these conditions and a further 10% reduction of cell number in relation to probiotic yeasts was observed. The tested strains, except for kefir isolates, were able to grow at 37°C. All the tested strains survived in sufficient number to create the possibility of proper action in the human body, although fecal, probiotic and collection strains tolerated the conditions of the human gastrointestinal tract better than food-borne yeasts.
Introduction
Probiotic yeasts are non-pathogenic strains belonging to the species Saccharomyces cerevisiae var. boulardii (Ouwehand et al., 2002) . Probiotic cultures have been used as both a preventive and therapeutic agent for the treatment of a variety of diarrheal diseases. S. cerevisiae var. boulardii is reported to be effective in the treatment for diarrhea in adults and children infected with Clostridium difficile, for diarrhea in human immunodeficiency virus-infected patients and for acute and chronic diarrhea in children and adults (McFarland and Bernasconi, 1993; Ouwehand et al., 2002) . Potential mechanisms of their probiotic activity are based on secretion of proteases or inhibitory proteins, stimulation of immunoglobulin A, acquisition and elimination of secreted toxins (Fooks and Gibson, 2002; McFarland and Bernasconi, 1993) .
A set of selection criteria considered to be relevant for any probiotic microorganism has been proposed by Ouwehand et al. (1999) . Tolerance to low pH and bile salts is seen as a prerequisite for strain survival through the gastrointestinal tract. Probiotics must be also able to resist to certain local stresses such as the presence of gastrointestinal enzymes, organic acids and temperature 37°C (Conway, 1996; Ouwehand et al., 1999) .
The taxonomic characterization of Saccharomyces cerevisiae var. boulardii is still controversial. On the basis of molecular typing techniques this group of yeasts was initially identified as a separate species of the genus Saccharomyces i.e. Saccharomyces boulardii (McFarland, 1996) . However, the development of molecular phylogenetics has led to changes in the classification of many yeast species (Liti et al., 2006; Vaughan-Martini, 2003) . Using comparative genomic hybridizations for whole-genome analysis S. boulardii and S. cerevisiae were reported as members of the same species (Edwards-Ingram et al., 2004) . In this context, the question appears if other S. cerevisiae strains demonstrate probiotic features as well.
In the present study, yeasts isolated from fermented milk products and chicken feces have been examined to evaluate their potentially probiotic properties. They have been classified taxonomically and compared to other Saccharomyces spp. strains of evidenced probiotic activities.
Experimental Materials and Methods
Yeast strains. Two strains isolated from two different kefirs (S11, S12) and one strain isolated from chicken faces (S10) were examined and compared with three probiotic strains isolated from medicines: Enterol ® 250 Biocodex, Hamadin ® N Dr. Willmar Schwabe, Omniflora ® Akut Novartis and Saccharomyces cerevisiae var. boulardii MYA-796, MYA-797 originated from the American Type Culture Collection. Yeasts were kept on YPD (1% yeast extract, 2% peptone, 2% dextrose) agar slants and maintained at 20°C in YPD broth containing 20% (v/v) glycerol.
Analysis of chromosomal DNA. Chromosomes of yeast strains were isolated and separated by pulsedfield gel electrophoresis PFGE. The typical conditions for preparation of chromosomal DNA from the Saccharomyces yeasts were followed (Schwarz and Cantor, 1984) . Yeast chromosomes were separated with a CHEF-DR II apparatus (Bio-Rad) in TBE buffer (Sigma) at 10°C and an interpolation of pulsed time of 110120 s for 26 hours. The gel was stained in ethidium bromide for visualization of nuclear DNA. A standard set of S. cerevisiae YNN 295 chromosomes was obtained commercially (Bio-Rad) and used for comparison.
Tolerance to low pH. Cultures activated by two transfers in liquid YPD were centrifuged (3000 × g, 10 min, 4°C) and cells were resuspended in sterile phosphate buffered saline PBS (0.8% sodium chloride, 0.02% potassium chloride, 0.144% disodium phosphate, 0.024% potassium phosphate, pH 7.4). Low pH tolerance was estimated by inoculating (10 6 cfu/ml) activated cultivates into PBS with pH adjusted at 1.5 and 2.5 with 3N HCl. The samples were incubated at 37°C and the number of viable cells was determined by the count plate method after 1, 2, 3, 4, 6 and 8 hours of incubation. The results are given as the mean value of three replicates and expressed as percentage log survival, calculated according to Williamson and Johnson (1981) :
Percentage log survival = (log N / log N 0 ) × 100 where N count (cfu/ml) after incubation, N 0 count at time 0 (cfu/ml).
Bile tolerance. Cultures activated as described above were inoculated into liquid YPD medium supplemented with 0.1% and 1.0% mixture of synthetic bile salts (50% sodium cholate and 50% sodium deoxycholate). Bile tolerance was also evaluated in liquid YPD medium with addition of 0.1% and 1.0% ox gall. The number of yeast cells was estimated by the count plate method after 20, 40, 60, 120, 180 and 240 minutes of incubation at 37°C. The results are given as the mean value of three replicates and presented as log cfu/ml. Results are presented in graphic form.
In vitro survival in gastric and intestinal environment. Activated cells were harvested by centrifugation at 3000× g for 10 min and inoculated at the level 10 6 cfu/ml in a simulated gastric environment aqueous solution containing 3 g/l pepsin (3260 U/mg) and 5 g/l NaCl, pH 2.0 (Charteris et al., 1998) . Yeast cultures were also inoculated into medium reproducing human intestine conditions, constituted by an aqueous solution containing 1 g/l pancreatin (903 U/mg) and 5 g/l NaCl, pH 8.0. The cell viability was determined by the count plate method after 20, 40, 60, 120, 180 and 240 minutes of incubation at 37°C. The results are given as the mean value of three replicates and presented as percentage log survival (Williamson and Johnson, 1981) .
Growth at 28 and 37°C. Growth at different temperatures was estimated by inoculating (10 6 cfu/ml) activated cultures into YPD liquid medium. The samples were incubated at 28 and 37°C for 48 hours and the number of cells was determined by the count plate method. In order to compare growth curves the Gompertz equation in conjuction with DMFit program was used (Baranyi and Roberts, 1994) . The Gompertz parameter values (A, B, C, M) were used to calculate exponential growth rates EGRs, generation times GTs, lag phase durations LPDs as described by Zaika et al. (1998) .
Statistical analysis. Results were analysed using 3-way ANOVA at the confidence level of p< 0.05. Results of the population viability were presented as the arithmetic mean of three assays with standard deviation not exceeding 0.2 logarithmic units.
Results
Fecal and kefir isolates were identified as Saccharomyces cerevisiae according to their morphological characteristics, ability to assimilate carbon and nitrogen compounds and sugar fermentation patterns (data not shown). On the basis of karyotypes the tested strains were classified to the genus Saccharomyces, since they show 1112 bands of a size varying between 200 and 2.300 kb (Fig. 1 ). There were differences in both the number and length of bands in electrophoregram of yeast S10S12 chromosomal DNA. The fecal isolate S10 and one of the kefir strain S11 showed 11 bands whereas the other strain derived from kefir S12 had 12 chromosomes. The electrophoretic patterns confirmed that probiotic and collection yeasts belong to the genus Saccharomyces. The chromosomal patterns of four S. cerevisiae var. boulardii strains (Hamadin ® , Omniflora ® , MYA-796, MYA-797) did not show polymorphism and consisted of 13 bands sized 2222251 kb (Fig. 1) . Only the karyotype of the probiotic strain isolated from Enterol ® was distinctive with additional chromosome 1884 kb.
The yeasts were characterized by high adaptation to conditions of the human gastrointestinal tract. The survival of all tested strains in medium of pH 2.5 was comparable and equaled 86.897.1% after 8 hours of incubation at 37°C (Table I) . Decrease in pH to 1.5 led to further reduction in cell viability and the survival was 85.392.1% in the case of fecal, probiotic and collection strains. The kefir isolates showed higher sensitivity to pH 1.5 and their survival was 33.1 and 38.9% after 8 hours of incubation.
Fecal and kefir isolates as well as probiotic and collection strains demonstrated high resistance to bile salts. The addition of 0.1 and 1.0% ox bile did not restrict viability of microorganisms (Fig. 2 ). In medium with 1.0% synthetic bile salts reduction of cell numbers by 1 log unit after four hours of incubation was observed for the fecal isolate S10, probiotic and collection yeasts. The least bile salts tolerant were kefir S10 yeasts (S11 and S12) but even their populations decreased by only 2 log units in the course of experiment.
In simulated gastric and intestinal environment the survival of all tested yeasts equaled 75.593. 2% and 83.197 .3% after 4 hours of incubation in media with pepsin and pancreatin, respectively (Table II) . It was found that the fecal isolate S10, probiotic and collection yeasts expressed comparable tolerance to the presence of gastrointestinal enzymes and the differences among strains amounted to less than 7%. Compared to these yeasts the kefir isolates S11 and S12 were more affected by exposure to the enzymes and the low pH. It seems that factor which stronger restricted the viability of yeasts was pH, much lower in medium reproducing conditions in human stomach than in human intestine.
The fecal isolate S10, the probiotic yeasts and the collection strains were able to grow at 37°C. In most cases decrease in the rate of growth and lower yield compared to the growth at optimal temperature 28°C were noted (Table III) . Interestingly, except for the probiotic Omniflora ® strain, 4280% shortening of lag phase was observed at 28°C. The kefir isolates S11 and S12 were incapable of growth at 37°C, but nevertheless their survival after 48 hours of incubation at 37°C was 92.5%.
Discussion
On the basis of chromosomal patterns the kefir and fecal isolates were identified as Saccharomyces spp. and the classification of probiotic and collection strains to the genus Saccharomyces was confirmed. Similar results were obtained for dozens of yeasts belonging to Saccharomyces sensu stricto group (Cardinali and Martini, 1994; Naumov et al., 2001; Vaughan-Martini et al., 1993) . However, positive yeast identification at the species level is very difficult because of chromosomal length polymorphism (Fietto et al., 2004; Naumov et al., 2001; Pataro et al., 2000) . VaughanMartini et al. (1993) concluded that none of the species of genus Saccharomyces could be distinguished by the consistent presence or absence of a unique band or cluster of bands. Some taxonomic studies (Mitterdorfer et al., 2002; Van der Aa Kühle et al., 2001) have indicated that S. boulardii should be considered as a strain of S. cerevisiae. This conclusion was confirmed by analysis of DNA polymorphism (Molnar et al., 1995) and reports of 95% DNA homology between S. cerevisiae and S. boulardii (Vaughan-Martini and Martini, 1987) . These findings are reflected in current nomenclature and according to the International Code of Botanical Nomenclature strains S. boulardii comprise the subtype of the S. cerevisiae species and should be referred as S. cerevisiae var. boulardii.
Interestingly, in several studies no variations in the genotype of S. cerevisiae var. boulardii have been observed (Cardinali and Martini, 1994; Hannequin et al., 2001; Malgoire et al., 2005; McFarland, 1996) , which is in disagreement with the results of present work. Recently, Klingberg et al. (2008) found that probiotic strains isolated from medicines Levucell ® SB and Precosa ® had identical profiles but clustered together with the probiotic isolates get from UltraLevure ® at a similarity of about 90%. Most definitions of probiotics emphasize that the microorganisms should be viable and reach their site of action alive (Ouwehand et al., 1999) . The primary barrier in the stomach is the gastric acid of inhibitory action being related to low pH and enzyme presence. All the tested yeasts showed high tolerance to these conditions, however kefir isolates were more sensitive than the probiotic, collection and fecal strains. It seems that the factor which could influence stronger the growth of yeasts was pH. There were significant differences between yeast survival in medium of pH 2.5 and 1.5 for food-borne isolates S11 and S12 (47.9 and 54.6%, respectively). Normal values for human gastric pH are 13 fasting and up to 5 after a meal (Cummings et al., 2004) and average stomach transit time is 2.54 hours (Camilleri et al., 1989) . We assumed stricter conditions in our investigation and examined yeasts survival during 8 hours of incubation in medium of very low pH. In these harsh conditions sufficient viable cells of all the tested strains could enter the small intestine indicating the possibility of their survival and proper activity in the human intestine.
Besides tolerance to acid conditions, all the tested yeasts demonstrated the ability to withstand 1.0% ox gall. Similar results have been reported previously for S. cerevisiae strains isolated from infant feces, feta cheese and beverages (Psomas et al., 2001; Van der Aa Kühle et al., 2005) . Bile tolerance is important for allowing a microorganism to survive in the intestinal tract (Gilliland et al., 1984) .
Growth at 37°C seems to be a variable characteristic of S. cerevisiae (Barnett et al., 2000) . In this study the fecal isolate S10, all probiotic and collection yeasts were able to grow at this temperature, in contrast to two strains isolated from kefirs. Nevertheless, the survival of these strains equaled 97.9% for S11 and 86.9% for S12 after 48 hours of incubation at 37°C.
Generally, isolates from feces, probiotic strains derived from medications and collection strains are able to grow at the temperature of 37°C and tolerate better the low pH, presence of gastrointestinal enzymes and bile salts than kefir yeasts. This finding is consistent with the conclusion of the importance of yeast origins for probiotic properties (Ouwehand et al., 1999) . However, irrespective of strain origins, all the tested yeasts may survive passage throughout the upper gastrointestinal tract and be viable at their sites of action in the gut environment.
The results of the present study suggest that all tested yeasts may survive in the human gastrointestinal tract and thus create the possibility of proper activity in the human body.
